Edwards Lifesciences's total assets for Q2 2024 were $10.10B, an increase of 3.73% from the previous quarter. GB:0REN total liabilities were $2.59B for the fiscal quarter, a 1.76% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.